# enCore Energy Corp.: financial statements, quarterly

EU · Nasdaq · CIK 1500881 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eu.md) · [Financials](/companies/eu/financials.md) · [Filings](/companies/eu/filings.md) · [Insiders](/companies/eu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eu/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [30.4](/filings/0001500881-25-000005.md) | [5.3](/filings/0001500881-25-000007.md) | [9.3](/filings/0001628280-25-050914.md) | [13.4](/filings/0001500881-25-000002.md) | [18.2](/filings/0001628280-26-035003.md) | [3.7](/filings/0001628280-26-056452.md) | [8.9](/filings/0001628280-25-050914.md) | [12.4 d](/filings/0001628280-26-022507.md) | [18.3](/filings/0001628280-26-035003.md) | [15.7](/filings/0001628280-26-056452.md) |
| Cost of revenue | $m | [30.9](/filings/0001500881-25-000005.md) | [10.4](/filings/0001500881-25-000007.md) | [10.6](/filings/0001628280-25-050914.md) | [13.7](/filings/0001500881-25-000002.md) | [18.3](/filings/0001628280-26-035003.md) | [2.5](/filings/0001628280-26-056452.md) | [5.0](/filings/0001628280-25-050914.md) | [7.7 d](/filings/0001628280-26-022507.md) | [18.4](/filings/0001628280-26-035003.md) | [18.3](/filings/0001628280-26-056452.md) |
| Gross profit | $m | [(0.5)](/filings/0001500881-25-000005.md) | [(5.1)](/filings/0001500881-25-000007.md) | [(1.3)](/filings/0001628280-25-050914.md) | [(0.3)](/filings/0001500881-25-000002.md) | [(0.0)](/filings/0001628280-26-035003.md) | [1.1](/filings/0001628280-26-056452.md) | [3.9](/filings/0001628280-25-050914.md) | [4.7 d](/filings/0001628280-26-022507.md) | [(0.1)](/filings/0001628280-26-035003.md) | [(2.6)](/filings/0001628280-26-056452.md) |
| Operating income | $m | [(12.3)](/filings/0001500881-25-000005.md) | [(23.0)](/filings/0001500881-25-000007.md) | [(17.4)](/filings/0001628280-25-050914.md) | [(20.1)](/filings/0001500881-25-000002.md) | [(15.6)](/filings/0001628280-26-035003.md) | [(19.3)](/filings/0001628280-26-056452.md) | [(14.0)](/filings/0001628280-25-050914.md) | [(16.8) d](/filings/0001628280-26-022507.md) | [10.0](/filings/0001628280-26-035003.md) | [(29.5)](/filings/0001628280-26-056452.md) |
| Interest expense | $m | [0.4](/filings/0001500881-25-000005.md) | [0.4](/filings/0001500881-25-000007.md) | [0.4](/filings/0001628280-25-050914.md) | [0.4](/filings/0001500881-25-000002.md) | [0.3](/filings/0001628280-26-035003.md) | [0.2](/filings/0001628280-26-056452.md) | [1.1](/filings/0001628280-25-050914.md) | [1.8 d](/filings/0001628280-26-022507.md) | [1.8](/filings/0001628280-26-035003.md) | [1.8](/filings/0001628280-26-056452.md) |
| Income tax | $m | [(5.1)](/filings/0001500881-25-000005.md) | [(0.3)](/filings/0001500881-25-000007.md) | [(0.3)](/filings/0001628280-25-050914.md) | [0.0](/filings/0001500881-25-000002.md) | [(0.2)](/filings/0001628280-26-035003.md) | [0.0](/filings/0001628280-26-056452.md) | [0.1](/filings/0001628280-25-050914.md) | [(0.4) d](/filings/0001628280-26-022507.md) | [(0.2)](/filings/0001628280-26-035003.md) | [0.0](/filings/0001628280-26-056452.md) |
| Net income | $m | [(7.3)](/filings/0001500881-25-000005.md) | [(22.0)](/filings/0001500881-25-000007.md) | [(15.8)](/filings/0001628280-25-050914.md) | [(17.1)](/filings/0001500881-25-000002.md) | [(24.2)](/filings/0001628280-26-035003.md) | [(6.3)](/filings/0001628280-26-056452.md) | [(4.8)](/filings/0001628280-25-050914.md) | [(21.5) d](/filings/0001628280-26-022507.md) | [5.4](/filings/0001628280-26-035003.md) | [(41.4)](/filings/0001628280-26-056452.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001500881-25-000005.md) | [(0.12)](/filings/0001500881-25-000007.md) | [(0.09)](/filings/0001628280-25-050914.md) | [(0.09)](/filings/0001500881-25-000002.md) | [(0.13)](/filings/0001628280-26-035003.md) | [(0.03)](/filings/0001628280-26-056452.md) | [(0.03)](/filings/0001628280-25-050914.md) | not reported | [0.03](/filings/0001628280-26-035003.md) | [(0.21)](/filings/0001628280-26-056452.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001500881-25-000005.md) | [(0.12)](/filings/0001500881-25-000007.md) | [(0.09)](/filings/0001628280-25-050914.md) | [(0.09)](/filings/0001500881-25-000002.md) | [(0.13)](/filings/0001628280-26-035003.md) | [(0.03)](/filings/0001628280-26-056452.md) | [(0.03)](/filings/0001628280-25-050914.md) | not reported | [0.03](/filings/0001628280-26-035003.md) | [(0.21)](/filings/0001628280-26-056452.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.5](/filings/0001213900-24-027149.md) | [7.5](/filings/0001500881-25-000002.md) | [90.1](/filings/0001500881-25-000002.md) | [55.8](/filings/0001500881-25-000002.md) | [46.3](/filings/0001500881-25-000002.md) | [39.7](/filings/0001628280-26-022507.md) | [29.7](/filings/0001500881-25-000005.md) | [26.9](/filings/0001500881-25-000007.md) | [91.9](/filings/0001628280-25-050914.md) | [52.4](/filings/0001628280-26-056452.md) | [41.6](/filings/0001628280-26-035003.md) | [21.8](/filings/0001628280-26-056452.md) |
| Current assets | $m | [10.6](/filings/0001213900-24-027149.md) | [25.3](/filings/0001500881-25-000002.md) | [122](/filings/0001500881-25-000002.md) | [106](/filings/0001500881-25-000002.md) | [96.0](/filings/0001500881-25-000002.md) | [87.4](/filings/0001628280-26-022507.md) | [54.0](/filings/0001500881-25-000005.md) | [49.9](/filings/0001500881-25-000007.md) | [129](/filings/0001628280-25-050914.md) | [110](/filings/0001628280-26-056452.md) | [134](/filings/0001628280-26-035003.md) | [99.5](/filings/0001628280-26-056452.md) |
| Total assets | $m | [224](/filings/0001213900-24-027149.md) | [327](/filings/0001500881-25-000002.md) | [423](/filings/0001500881-25-000002.md) | [408](/filings/0001500881-25-000002.md) | [398](/filings/0001500881-25-000002.md) | [393](/filings/0001628280-26-022507.md) | [363](/filings/0001500881-25-000005.md) | [359](/filings/0001500881-25-000007.md) | [442](/filings/0001628280-25-050914.md) | [430](/filings/0001628280-26-056452.md) | [452](/filings/0001628280-26-035003.md) | [417](/filings/0001628280-26-056452.md) |
| Current liabilities | $m | [3.6](/filings/0001213900-24-027149.md) | [6.3](/filings/0001500881-25-000002.md) | [24.1](/filings/0001500881-25-000002.md) | [24.2](/filings/0001500881-25-000002.md) | [27.2](/filings/0001500881-25-000002.md) | [30.1](/filings/0001628280-26-022507.md) | [18.4](/filings/0001500881-25-000005.md) | [19.7](/filings/0001500881-25-000007.md) | [9.5](/filings/0001628280-25-050914.md) | [13.7](/filings/0001628280-26-056452.md) | [12.1](/filings/0001628280-26-035003.md) | [12.4](/filings/0001628280-26-056452.md) |
| Total liabilities | $m | [8.5](/filings/0001213900-24-027149.md) | [64.6](/filings/0001500881-25-000002.md) | [62.3](/filings/0001500881-25-000002.md) | [62.5](/filings/0001500881-25-000002.md) | [65.7](/filings/0001500881-25-000002.md) | [74.2](/filings/0001628280-26-022507.md) | [62.7](/filings/0001500881-25-000005.md) | [64.5](/filings/0001500881-25-000007.md) | [164](/filings/0001628280-25-050914.md) | [172](/filings/0001628280-26-056452.md) | [170](/filings/0001628280-26-035003.md) | [172](/filings/0001628280-26-056452.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-022507.md) | not reported | not reported | [109](/filings/0001628280-25-050914.md) | [110](/filings/0001628280-26-056452.md) | [110](/filings/0001628280-26-035003.md) | [110](/filings/0001628280-26-056452.md) |
| Short-term borrowings | $m | not reported | not reported | [20.3](/filings/0001500881-25-000002.md) | [20.7](/filings/0001500881-25-000002.md) | [21.2](/filings/0001500881-25-000002.md) | [20.1](/filings/0001628280-26-022507.md) | [10.1](/filings/0001500881-25-000005.md) | [10.1](/filings/0001500881-25-000007.md) | [0.0](/filings/0001628280-25-050914.md) | [0.0](/filings/0001628280-26-022507.md) | not reported | not reported |
| Shareholders' equity | $m | [196](/filings/0001500881-25-000002.md) | [262](/filings/0001500881-25-000002.md) | [321](/filings/0001500881-25-000002.md) | [308](/filings/0001500881-25-000002.md) | [298](/filings/0001500881-25-000002.md) | [286](/filings/0001628280-26-022507.md) | [268](/filings/0001500881-25-000005.md) | [265](/filings/0001500881-25-000007.md) | [249](/filings/0001628280-25-050914.md) | [229](/filings/0001628280-26-056452.md) | [255](/filings/0001628280-26-035003.md) | [222](/filings/0001628280-26-056452.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: ifrs-full:CurrentAssets, us-gaap:AssetsCurrent
- Total assets: ifrs-full:Assets, us-gaap:Assets
- Current liabilities: ifrs-full:CurrentLiabilities, us-gaap:LiabilitiesCurrent
- Total liabilities: ifrs-full:Liabilities, us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.0)](/filings/0001500881-25-000005.md) | [(37.1) d](/filings/0001500881-25-000007.md) | [(5.5) d](/filings/0001628280-25-050914.md) | [0.4 d](/filings/0001628280-26-022507.md) | [(7.7)](/filings/0001628280-26-035003.md) | [(9.9) d](/filings/0001628280-26-056452.md) | [(20.3) d](/filings/0001628280-25-050914.md) | [12.9 d](/filings/0001628280-26-022507.md) | [(21.4)](/filings/0001628280-26-035003.md) | [(21.1) d](/filings/0001628280-26-056452.md) |
| Capital expenditure | $m | [1.6](/filings/0001500881-25-000005.md) | [2.2 d](/filings/0001500881-25-000007.md) | [1.5 d](/filings/0001628280-25-050914.md) | [6.1 d](/filings/0001628280-26-022507.md) | [4.0](/filings/0001500881-25-000005.md) | [4.2 d](/filings/0001500881-25-000007.md) | [6.0 d](/filings/0001628280-25-050914.md) | [5.8 d](/filings/0001628280-26-022507.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [173](/filings/0001500881-25-000005.md) | [183](/filings/0001500881-25-000007.md) | [185](/filings/0001628280-25-050914.md) | [186](/filings/0001500881-25-000002.md) | [186](/filings/0001628280-26-035003.md) | [187](/filings/0001628280-26-056452.md) | [187](/filings/0001628280-25-050914.md) | [191](/filings/0001628280-26-035003.md) | [194](/filings/0001628280-26-056452.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 194,280,971 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056452.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.